Annotation Detail for WDR41
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of WDR41 mRNA | decreases expression | 20458559
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of WDR41 mRNA | increases expression | 20106945
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.37 | 19825857 11798837 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
4.22 | 16206674 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.94 | 11589617 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
1.99 | 15073043 16217749 15553829 14691202 11135700 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.94 | 19014326 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.63 | 12490120 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.85 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.28 | 19486331 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.87 | 20501625 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.86 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
1.90 | 10525206 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.70 | 15213294 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.40 | 12903497 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
9.64 | 15073043 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.64 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.90 | 12168785 12639820 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.94 | 16904648 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
5.11 | 8708960 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.31 | 15720958 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.24 | 10903974 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.51 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.58 | 8314463 18776723 10903974 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.17 | 12371664 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
3.03 | 15070760 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.35 | 12560223 17077332 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
5.19 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.79 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
4.31 | 19077051 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.19 | 16467208 16968895 19850784 20471514 17050201 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.51 | 15748426 15622746 19035177 11161223 9834237 16891316 17712046 17869043 16331271 16112521 12712474 17649720 19642359 19075265 15336539 12018890 17107899 19225113 17217047 16966277 16823087 15213294 11468182 12679006 16330433 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
5.03 | 16882451 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
2.48 | 14682389 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
3.01 | 20377131 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.73 | 15213294 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
1.87 | 19825857 11798837 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.86 | 16801185 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.44 | 19417148 14977855 19549372 11468182 15949261 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.74 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.38 | 16882451 16105982 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.63 | 16624393 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.51 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.75 | 19348381 18481113 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.41 | 10525206 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.52 | 16624393 12452020 19769630 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.66 | 15580305 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.77 | 19927285 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.69 | 12371664 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.20 | 19131511 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.35 | 16882103 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.63 | 16646077 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.47 | 19014326 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.85 | 15213294 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.62 | 12845720 12973940 20435036 11780464 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
5.05 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.51 | 17120751 |
Related Pathway Information